封面
市場調查報告書
商品編碼
1757439

妊娠紋治療市場:全球產業分析、市場規模、佔有率、成長、趨勢與未來預測(2025-2032)

Stretch Marks Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日期: | 出版商: Persistence Market Research | 英文 201 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發布了一份關於全球妊娠紋治療市場的綜合報告。該報告全面評估了市場促進因素、趨勢、機會、促進因素和挑戰等關鍵市場動態,並深入分析了市場結構。研究報告提供了獨家數據和統計數據,概述了 2025 年至 2032 年全球妊娠紋治療市場的預測成長軌跡。

關鍵見解

  • 妊娠紋治療市場規模(2025年):29.234億美元
  • 市場規模預測(以金額為準,2032 年):43.38 億美元
  • 全球市場成長率(2025-2032年複合年成長率):5.8%

妊娠紋治療市場:分析範圍

妊娠紋治療包括多種解決方案,旨在減少或消除妊娠紋(膨脹紋),這些紋路是由懷孕、體重波動、荷爾蒙變化等引起的。療程多樣,從局部塗抹乳霜和精油,到雷射治療、微晶換膚和化學換膚,不一而足。妊娠紋治療市場面向皮膚科診所、美容中心、藥局和家庭消費者。人們日益增強的美容意識、非侵入性治療技術的進步以及對個人化護膚解決方案日益成長的需求,是妊娠紋治療發展的驅動力。

市場成長動力:

全球妊娠紋治療市場受多種關鍵因素驅動,例如對美容手術的需求不斷成長,尤其是在20至40歲女性群體中。人們對皮膚健康的認知不斷提高,以及飛梭雷射和射頻等微創治療手段的普及,正在推動市場對妊娠紋的接受度。此外,天然和有機護膚配方的日益普及,也推動了植物來源和草藥療法在妊娠紋護理領域的興起。社群媒體影響力人士、明星代言以及日益壯大的電商平台也顯著提升了消費者參與度和市場滲透率。

市場限制:

儘管妊娠紋治療市場成長潛力巨大,但也面臨許多限制因素,例如療效參差不齊以及產品類型缺乏標準化。雷射和微針等先進治療方法價格昂貴,限制了其普及性,尤其是在價格敏感的市場。此外,新化妝品配方核准的監管複雜性以及化學療法的潛在副作用可能會阻礙市場擴張。消費者對產品功效的質疑以及見效時間的長短,也對推廣應用構成了進一步的挑戰。

市場機會:

妊娠紋治療市場蘊含著巨大的商機,這得益於護膚配方的創新、皮膚科服務的拓展以及男性對美容護理日益成長的興趣。亞太和拉丁美洲新興市場的消費者在美容和個人護理方面的支出正在成長,這為市場提供了新的成長途徑。集抗衰老、保濕和改善妊娠紋功效於一體的多功能產品的開發,可望刺激產品需求。此外,遠距皮膚科和線上護膚諮詢將擴大消費者機會專家指導的管道,從而改善治療效果並提升市場參與。化妝品品牌、皮膚科醫生和生技公司之間的合作有望催生新的治療方法,並開拓新的細分市場。

本報告回答的關鍵問題

  • 推動全球妊娠紋治療市場成長的關鍵因素有哪些?
  • 哪些治療類型和交付管道在各個消費者群體中越來越受歡迎?
  • 技術進步和天然成分趨勢如何影響產品創新?
  • 哪些主要企業正在為妊娠紋治療市場做出貢獻,他們採取了哪些策略來維持市場相關性?
  • 全球妊娠紋治療市場有哪些新興趨勢與前景?

目錄

第1章執行摘要

第2章 市場概述

  • 市場範圍和定義
  • 價值鏈分析
  • 宏觀經濟因素
    • 世界GDP展望
    • 世界GDP展望
    • 全球經濟成長預測
    • 全球都市化進程
    • 其他宏觀經濟因素
  • 預測因子:相關性和影響力
  • COVID-19影響評估
  • PESTLE分析
  • 波特五力分析
  • 地緣政治緊張局勢:市場影響
  • 監管和技術格局

第3章 市場動態

  • 驅動程式
  • 限制因素
  • 機會
  • 趨勢

第4章 價格趨勢分析(2019-2032)

  • 區域定價分析
  • 按細分市場定價
  • 影響價格的因素

第5章。全球妊娠紋治療市場展望:過去(2019-2024 年)與預測(2025-2032 年)

  • 主要亮點
  • 全球妊娠紋治療市場(按治療方法)展望
    • 簡介/主要發現
    • 治療方法的歷史市場規模表現(價值(百萬美元),2019-2024 年)
    • 目前市場規模預測(按治療方法分類)(價值(百萬美元),2025-2032 年)
      • 外用藥物
        • 凝膠
        • 奶油
        • 油/精華液
      • 程序性治療
        • 射頻治療
        • 非剝脫性點陣表面置換
        • 燒蝕雷射表面置換
        • 紅外線設備/輻射
        • 皮膚脫皮
        • 化學換膚
    • 市場吸引力分析:按治療方法
  • 全球妊娠紋治療市場展望(依妊娠紋類型分類)
    • 簡介/主要發現
    • 妊娠紋類型歷史市場規模表現(價值(百萬美元),2019-2024 年)
    • 目前市場規模預測(按妊娠紋類型分類)(價值(百萬美元),2025-2032 年)
      • 萎縮性條紋(皮變薄)
      • 妊娠紋(產後)
      • 皮膚拉伸(皮膚拉伸)
      • 深紅色條紋(紅色)
      • 條紋(白色)
      • 黑條紋(黑色)
      • 青色條紋(深藍色)
    • 依妊娠紋類型進行市場吸引力分析
  • 全球妊娠紋治療市場前景(依最終用戶)
    • 簡介/主要發現
    • 按最終用戶分類的歷史市場規模表現(價值(百萬美元),2019-2024 年)
    • 目前市場規模預測(按最終用戶分類)(價值(百萬美元),2025-2032 年)
      • 醫院
      • 皮膚科診所
      • 美容診所
      • 健康水療中心
      • 居家醫療
    • 最終用戶的市場吸引力分析

第6章全球妊娠紋治療市場按地區展望

  • 主要亮點
  • 按地區分類的歷史市場規模分析(價值(百萬美元),2019-2024 年)
  • 各地區目前市場規模預測(價值(百萬美元),2025-2032 年)
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析:按地區

第7章北美妊娠紋治療市場展望:歷史(2019-2024 年)與預測(2025-2032 年)

第 8 章歐洲妊娠紋治療市場展望:歷史(2019-2024 年)與預測(2025-2032 年)

第9章東亞妊娠紋治療市場展望:歷史(2019-2024)與預測(2025-2032)

第 10 章南亞和大洋洲妊娠紋治療市場展望:歷史(2019-2024 年)和預測(2025-2032 年)

第 11 章拉丁美洲妊娠紋治療市場展望:歷史(2019-2024 年)與預測(2025-2032 年)

第 12 章中東和非洲妊娠紋治療市場展望:歷史(2019-2024 年)和預測(2025-2032 年)

第13章競爭格局

  • 市場佔有率分析(2025年)
  • 市場結構
    • 競爭強度圖:按市場
    • 競爭儀錶板
  • 公司簡介
    • Weleda
    • Clarins
    • basq NYC
    • Body Merry
    • Himalaya Global Holdings Ltd.
    • Stratpharma AG(Stratpharma Inc.)
    • Browne Drug Co., Inc.(Palmer's)
    • Mederma(HRA Pharma)
    • Givaudan SA
    • NEOSTRATA COMPANY, INC.(Johnson &Johnson Services, Inc.)
    • Bio-Oil(Union Swiss(Pty)Ltd)
    • Merz Pharma
    • Dermaclara
    • Unilever

第14章 附錄

  • 調查方法
  • 調查前提
  • 首字母縮寫和簡稱
簡介目錄
Product Code: PMRREP33375

Persistence Market Research has recently released a comprehensive report on the worldwide market for stretch marks treatment. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global stretch marks treatment market from 2025 to 2032.

Key Insights:

  • Stretch Marks Treatment Market Size (2025E): USD 2,923.4 Million
  • Projected Market Value (2032F): USD 4,338.0 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.8%

Stretch Marks Treatment Market - Report Scope:

Stretch marks treatment includes a variety of solutions aimed at minimizing or eliminating the appearance of striae distensae (stretch marks), commonly resulting from pregnancy, weight fluctuations, or hormonal changes. Treatment methods range from topical creams and oils to laser therapy, microdermabrasion, and chemical peels. The stretch marks treatment market caters to dermatology clinics, beauty centers, pharmacies, and at-home consumers. Growth is driven by increasing aesthetic awareness, advancements in non-invasive treatment technologies, and growing demand for personalized skincare solutions.

Market Growth Drivers:

The global stretch marks treatment market is propelled by several key factors, including the rising demand for aesthetic procedures, particularly among women aged 20-40. Increased awareness of dermatological health and the availability of minimally invasive treatments such as fractional lasers and radiofrequency therapy are accelerating market adoption. Furthermore, the growing popularity of natural and organic skincare formulations supports the rise of plant-based and herbal remedies in stretch marks care. Social media influence, celebrity endorsements, and expanding e-commerce platforms are also major contributors to consumer engagement and market penetration.

Market Restraints:

Despite strong growth potential, the stretch marks treatment market faces notable restraints, such as inconsistent treatment efficacy and lack of standardization across product categories. The high cost of advanced treatment modalities like laser and microneedling therapy limits accessibility, particularly in price-sensitive markets. Additionally, regulatory complexities concerning the approval of new cosmetic formulations and potential side effects of chemical-based treatments can hinder market expansion. Consumer skepticism regarding product claims and the long duration required to see visible results further challenge widespread adoption.

Market Opportunities:

The stretch marks treatment market presents substantial opportunities driven by innovation in skincare formulations, expansion of dermatological services, and growing male interest in aesthetic treatments. Emerging markets in Asia Pacific and Latin America show increasing consumer spending on beauty and personal care, offering new growth avenues. The development of multifunctional products combining anti-aging, moisturizing, and stretch mark-reducing properties can boost product demand. In addition, teledermatology and online skincare consultations expand consumer access to expert guidance, improving treatment outcomes and market outreach. Collaborations between cosmetic brands, dermatologists, and biotech firms are likely to foster novel treatment approaches and unlock new market segments.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the stretch marks treatment market globally?
  • Which treatment types and delivery channels are gaining popularity among different consumer demographics?
  • How are technological advancements and natural ingredient trends shaping product innovation?
  • Who are the key players contributing to the stretch marks treatment market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global stretch marks treatment market?

Competitive Intelligence and Business Strategy:

These companies invest in R&D to develop clinically tested formulations enriched with ingredients like retinol, centella asiatica, and hyaluronic acid. Partnerships with dermatologists and beauty influencers, along with omnichannel distribution strategies, enhance consumer engagement. Emphasis on clean beauty, sustainability, and customized skincare solutions further drives competitive differentiation and consumer loyalty.

Key Companies Profiled:

  • Weleda
  • Clarins
  • basq NYC
  • Body Merry
  • Himalaya Global Holdings Ltd.
  • Stratpharma AG (Stratpharma Inc.)
  • Browne Drug Co., Inc. (Palmer's)
  • Mederma (HRA Pharma)
  • Givaudan SA
  • NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
  • Bio-Oil (Union Swiss (Pty) Ltd)
  • Merz Pharma
  • Dermaclara
  • Unilever

Stretch Marks Treatment Market Research Segmentation:

The stretch marks treatment market encompasses a diverse range of products, technologies, applications, and consumer segments, addressing varying degrees of skin damage and consumer preferences.

By Treatment:

Topical Medications

*Gels

*Creams

*Oils/Serums

Procedural Treatments

*Radiofrequency Therapy

*Non-ablative Laser Fractional Resurfacing

*Ablative Laser Resurfacing

*Infrared Devices/Radiations

*Dermabrasion

*Chemical Peels

By Stretch Mark Type:

  • Striae atrophicans (Thinned Skin)
  • Striae gravidarum (Post Pregnancy)
  • Striae distensae (Stretched Skin)
  • striae rubrae (Red)
  • Striae albae (White)
  • Striae nigra (Black)
  • Striae caerulea (Dark Blue)

By End User:

  • Hospitals
  • Dermatology Clinics
  • Aesthetic Clinics
  • Wellness and Spa Centers
  • Home Care Settings

By Region:

  • North America
  • Latin America
  • Europe Stretch
  • South Asia Stretch
  • East Asia Stretch
  • Oceania Stretch
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Stretch Marks Treatment Market Snapshot 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Industry Developments and Key Market Events
  • 1.5. Demand Side and Supply Side Analysis
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definitions
  • 2.2. Value Chain Analysis
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Outlook
    • 2.3.2. Global GDP Outlook
    • 2.3.3. Global economic Growth Forecast
    • 2.3.4. Global Urbanization Growth
    • 2.3.5. Other Macro-economic Factors
  • 2.4. Forecast Factors - Relevance and Impact
  • 2.5. COVID-19 Impact Assessment
  • 2.6. PESTLE Analysis
  • 2.7. Porter's Five Forces Analysis
  • 2.8. Geopolitical Tensions: Market Impact
  • 2.9. Regulatory and Technology Landscape

3. Market Dynamics

  • 3.1. Drivers
  • 3.2. Restraints
  • 3.3. Opportunities
  • 3.4. Trends

4. Price Trend Analysis, 2019-2032

  • 4.1. Region-wise Price Analysis
  • 4.2. Price by Segments
  • 4.3. Price Impact Factors

5. Global Stretch Marks Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 5.1. Key Highlights
  • 5.2. Global Stretch Marks Treatment Market Outlook: Treatment
    • 5.2.1. Introduction/Key Findings
    • 5.2.2. Historical Market Size (US$ Mn) Analysis by Treatment, 2019-2024
    • 5.2.3. Current Market Size (US$ Mn) Forecast, by Treatment, 2025-2032
      • 5.2.3.1. Topical Medications
        • 5.2.3.1.1. Gels
        • 5.2.3.1.2. Creams
        • 5.2.3.1.3. Oils/Serums
      • 5.2.3.2. Procedural Treatments
        • 5.2.3.2.1. Radiofrequency Therapy
        • 5.2.3.2.2. Non-ablative Laser Fractional Resurfacing
        • 5.2.3.2.3. Ablative Laser Resurfacing
        • 5.2.3.2.4. Infrared Devices/Radiations
        • 5.2.3.2.5. Dermabrasion
        • 5.2.3.2.6. Chemical Peels
    • 5.2.4. Market Attractiveness Analysis: Treatment
  • 5.3. Global Stretch Marks Treatment Market Outlook: Stretch Mark Type
    • 5.3.1. Introduction/Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) Analysis by Stretch Mark Type, 2019-2024
    • 5.3.3. Current Market Size (US$ Mn) Forecast, by Stretch Mark Type, 2025-2032
      • 5.3.3.1. Striae atrophicans (Thinned Skin)
      • 5.3.3.2. Striae gravidarum (Post Pregnancy)
      • 5.3.3.3. Striae distensae (Stretched Skin)
      • 5.3.3.4. striae rubrae (Red)
      • 5.3.3.5. Striae albae (White)
      • 5.3.3.6. Striae nigra (Black)
      • 5.3.3.7. Striae caerulea (Dark Blue)
    • 5.3.4. Market Attractiveness Analysis: Stretch Mark Type
  • 5.4. Global Stretch Marks Treatment Market Outlook: End User
    • 5.4.1. Introduction/Key Findings
    • 5.4.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2024
    • 5.4.3. Current Market Size (US$ Mn) Forecast, by End User, 2025-2032
      • 5.4.3.1. Hospitals
      • 5.4.3.2. Dermatology Clinics
      • 5.4.3.3. Aesthetic Clinics
      • 5.4.3.4. Wellness and Spa Centers
      • 5.4.3.5. Home Care Settings
    • 5.4.4. Market Attractiveness Analysis: End User

6. Global Stretch Marks Treatment Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
  • 6.3. Current Market Size (US$ Mn) Forecast, by Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia & Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Stretch Marks Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. North America Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. North America Market Size (US$ Mn) Forecast, by Treatment, 2025-2032
    • 7.4.1. Topical Medications
      • 7.4.1.1. Gels
      • 7.4.1.2. Creams
      • 7.4.1.3. Oils/Serums
    • 7.4.2. Procedural Treatments
      • 7.4.2.1. Radiofrequency Therapy
      • 7.4.2.2. Non-ablative Laser Fractional Resurfacing
      • 7.4.2.3. Ablative Laser Resurfacing
      • 7.4.2.4. Infrared Devices/Radiations
      • 7.4.2.5. Dermabrasion
      • 7.4.2.6. Chemical Peels
  • 7.5. North America Market Size (US$ Mn) Forecast, by Stretch Mark Type, 2025-2032
    • 7.5.1. Striae atrophicans (Thinned Skin)
    • 7.5.2. Striae gravidarum (Post Pregnancy)
    • 7.5.3. Striae distensae (Stretched Skin)
    • 7.5.4. striae rubrae (Red)
    • 7.5.5. Striae albae (White)
    • 7.5.6. Striae nigra (Black)
    • 7.5.7. Striae caerulea (Dark Blue)
  • 7.6. North America Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Dermatology Clinics
    • 7.6.3. Aesthetic Clinics
    • 7.6.4. Wellness and Spa Centers
    • 7.6.5. Home Care Settings

8. Europe Stretch Marks Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Europe Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. Italy
    • 8.3.3. France
    • 8.3.4. U.K.
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Rest of Europe
  • 8.4. Europe Market Size (US$ Mn) Forecast, by Treatment, 2025-2032
    • 8.4.1. Topical Medications
      • 8.4.1.1. Gels
      • 8.4.1.2. Creams
      • 8.4.1.3. Oils/Serums
    • 8.4.2. Procedural Treatments
      • 8.4.2.1. Radiofrequency Therapy
      • 8.4.2.2. Non-ablative Laser Fractional Resurfacing
      • 8.4.2.3. Ablative Laser Resurfacing
      • 8.4.2.4. Infrared Devices/Radiations
      • 8.4.2.5. Dermabrasion
      • 8.4.2.6. Chemical Peels
  • 8.5. Europe Market Size (US$ Mn) Forecast, by Stretch Mark Type, 2025-2032
    • 8.5.1. Striae atrophicans (Thinned Skin)
    • 8.5.2. Striae gravidarum (Post Pregnancy)
    • 8.5.3. Striae distensae (Stretched Skin)
    • 8.5.4. striae rubrae (Red)
    • 8.5.5. Striae albae (White)
    • 8.5.6. Striae nigra (Black)
    • 8.5.7. Striae caerulea (Dark Blue)
  • 8.6. Europe Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Dermatology Clinics
    • 8.6.3. Aesthetic Clinics
    • 8.6.4. Wellness and Spa Centers
    • 8.6.5. Home Care Settings

9. East Asia Stretch Marks Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. East Asia Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. East Asia Market Size (US$ Mn) Forecast, by Treatment, 2025-2032
    • 9.4.1. Topical Medications
      • 9.4.1.1. Gels
      • 9.4.1.2. Creams
      • 9.4.1.3. Oils/Serums
    • 9.4.2. Procedural Treatments
      • 9.4.2.1. Radiofrequency Therapy
      • 9.4.2.2. Non-ablative Laser Fractional Resurfacing
      • 9.4.2.3. Ablative Laser Resurfacing
      • 9.4.2.4. Infrared Devices/Radiations
      • 9.4.2.5. Dermabrasion
      • 9.4.2.6. Chemical Peels
  • 9.5. East Asia Market Size (US$ Mn) Forecast, by Stretch Mark Type, 2025-2032
    • 9.5.1. Striae atrophicans (Thinned Skin)
    • 9.5.2. Striae gravidarum (Post Pregnancy)
    • 9.5.3. Striae distensae (Stretched Skin)
    • 9.5.4. striae rubrae (Red)
    • 9.5.5. Striae albae (White)
    • 9.5.6. Striae nigra (Black)
    • 9.5.7. Striae caerulea (Dark Blue)
  • 9.6. East Asia Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Dermatology Clinics
    • 9.6.3. Aesthetic Clinics
    • 9.6.4. Wellness and Spa Centers
    • 9.6.5. Home Care Settings

10. South Asia & Oceania Stretch Marks Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. South Asia & Oceania Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of SAO
  • 10.4. South Asia & Oceania Market Size (US$ Mn) Forecast, by Treatment, 2025-2032
    • 10.4.1. Topical Medications
      • 10.4.1.1. Gels
      • 10.4.1.2. Creams
      • 10.4.1.3. Oils/Serums
    • 10.4.2. Procedural Treatments
      • 10.4.2.1. Radiofrequency Therapy
      • 10.4.2.2. Non-ablative Laser Fractional Resurfacing
      • 10.4.2.3. Ablative Laser Resurfacing
      • 10.4.2.4. Infrared Devices/Radiations
      • 10.4.2.5. Dermabrasion
      • 10.4.2.6. Chemical Peels
  • 10.5. South Asia & Oceania Market Size (US$ Mn) Forecast, by Stretch Mark Type, 2025-2032
    • 10.5.1. Striae atrophicans (Thinned Skin)
    • 10.5.2. Striae gravidarum (Post Pregnancy)
    • 10.5.3. Striae distensae (Stretched Skin)
    • 10.5.4. striae rubrae (Red)
    • 10.5.5. Striae albae (White)
    • 10.5.6. Striae nigra (Black)
    • 10.5.7. Striae caerulea (Dark Blue)
  • 10.6. South Asia & Oceania Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Dermatology Clinics
    • 10.6.3. Aesthetic Clinics
    • 10.6.4. Wellness and Spa Centers
    • 10.6.5. Home Care Settings

11. Latin America Stretch Marks Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Latin America Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of LATAM
  • 11.4. Latin America Market Size (US$ Mn) Forecast, by Treatment, 2025-2032
    • 11.4.1. Topical Medications
      • 11.4.1.1. Gels
      • 11.4.1.2. Creams
      • 11.4.1.3. Oils/Serums
    • 11.4.2. Procedural Treatments
      • 11.4.2.1. Radiofrequency Therapy
      • 11.4.2.2. Non-ablative Laser Fractional Resurfacing
      • 11.4.2.3. Ablative Laser Resurfacing
      • 11.4.2.4. Infrared Devices/Radiations
      • 11.4.2.5. Dermabrasion
      • 11.4.2.6. Chemical Peels
  • 11.5. Latin America Market Size (US$ Mn) Forecast, by Stretch Mark Type, 2025-2032
    • 11.5.1. Striae atrophicans (Thinned Skin)
    • 11.5.2. Striae gravidarum (Post Pregnancy)
    • 11.5.3. Striae distensae (Stretched Skin)
    • 11.5.4. striae rubrae (Red)
    • 11.5.5. Striae albae (White)
    • 11.5.6. Striae nigra (Black)
    • 11.5.7. Striae caerulea (Dark Blue)
  • 11.6. Latin America Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Dermatology Clinics
    • 11.6.3. Aesthetic Clinics
    • 11.6.4. Wellness and Spa Centers
    • 11.6.5. Home Care Settings

12. Middle East & Africa Stretch Marks Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 12.1. Key Highlights
  • 12.2. Pricing Analysis
  • 12.3. Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. South Africa
    • 12.3.3. Northern Africa
    • 12.3.4. Rest of MEA
  • 12.4. Middle East & Africa Market Size (US$ Mn) Forecast, by Treatment, 2025-2032
    • 12.4.1. Topical Medications
      • 12.4.1.1. Gels
      • 12.4.1.2. Creams
      • 12.4.1.3. Oils/Serums
    • 12.4.2. Procedural Treatments
      • 12.4.2.1. Radiofrequency Therapy
      • 12.4.2.2. Non-ablative Laser Fractional Resurfacing
      • 12.4.2.3. Ablative Laser Resurfacing
      • 12.4.2.4. Infrared Devices/Radiations
      • 12.4.2.5. Dermabrasion
      • 12.4.2.6. Chemical Peels
  • 12.5. Middle East & Africa Market Size (US$ Mn) Forecast, by Stretch Mark Type, 2025-2032
    • 12.5.1. Striae atrophicans (Thinned Skin)
    • 12.5.2. Striae gravidarum (Post Pregnancy)
    • 12.5.3. Striae distensae (Stretched Skin)
    • 12.5.4. striae rubrae (Red)
    • 12.5.5. Striae albae (White)
    • 12.5.6. Striae nigra (Black)
    • 12.5.7. Striae caerulea (Dark Blue)
  • 12.6. Middle East & Africa Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 12.6.1. Hospitals
    • 12.6.2. Dermatology Clinics
    • 12.6.3. Aesthetic Clinics
    • 12.6.4. Wellness and Spa Centers
    • 12.6.5. Home Care Settings

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles
    • 13.3.1. Weleda
      • 13.3.1.1. Company Overview
      • 13.3.1.2. Product Portfolio/Offerings
      • 13.3.1.3. Key Financials
      • 13.3.1.4. SWOT Analysis
      • 13.3.1.5. Company Strategy and Key Developments
    • 13.3.2. Clarins
    • 13.3.3. basq NYC
    • 13.3.4. Body Merry
    • 13.3.5. Himalaya Global Holdings Ltd.
    • 13.3.6. Stratpharma AG (Stratpharma Inc.)
    • 13.3.7. Browne Drug Co., Inc. (Palmer's)
    • 13.3.8. Mederma (HRA Pharma)
    • 13.3.9. Givaudan SA
    • 13.3.10. NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
    • 13.3.11. Bio-Oil (Union Swiss (Pty) Ltd)
    • 13.3.12. Merz Pharma
    • 13.3.13. Dermaclara
    • 13.3.14. Unilever

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations